Blog Posts

Mike Thompson: Myeloma/Plasma Cell Dyscrasia – Top Abstract Highlights from ASH24

Mike Thompson/LinkedIn

Nov 21, 2024, 16:11

Mike Thompson: Myeloma/Plasma Cell Dyscrasia – Top Abstract Highlights from ASH24

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:

“Myeloma/Plasma Cell Dyscrasia ~ ASH24Top10 (or so) Multiple Myeloma ASH24 by Mike Thompson

*DRAFT* Table Update: Nov 20, 2024″

ASH24 cancer Cell Dyscrasia Joseph Mikhael Mike Thompson multiple myeloma Myeloma OncoDaily Oncology Samer Al Hadidi Tempus

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Sep 7, 2025, 10:48

Julio Francisco Godoy Fernández: Behind Each Statistic is a Child’s Story

Voices

Sep 7, 2025, 10:39

Tanja Spanic: The Progress of Breast Cancer Treatment

Voices

Sep 7, 2025, 10:32

Suzanne Gronemeyer: Regan Hill Williams's Speech at the St. Jude Grand Rounds

Career Updates

Sep 7, 2025, 10:30

Ardem Patapoutian: Excited to Join the Scientific Advisory Board of Stratus Therapeutics

Blog Posts

Sep 7, 2025, 10:15

WCLC25 Brings Breakthroughs, Friendship, and Fun

Voices

Sep 7, 2025, 09:10

Roberto Borea: The Stellar WCLC25 Chairs Open the First Plenary Session

New Paper Alert

Sep 7, 2025, 09:06

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center

Voices

Sep 7, 2025, 08:48

Why Radiotherapy Matters: Access, Understanding, and Workforce Support - Lung Cancer Europe

Voices

Sep 7, 2025, 08:38

Raul Cordoba: e-PROMs in Lymphoma - Impact on Symptoms, Care Use, and Survival

Voices

Sep 7, 2025, 08:20

Christian Rolfo: Highlights from IASLC Educational Committee at WCLC25

Voices

Sep 7, 2025, 08:08

Kostas Syrigos: Keynote at Patients Advocacy Exchange at WCLC25

Career Updates

Sep 7, 2025, 07:58

Jarushka Naidoo: David O Reilly Wins IASLC Adi Gazdar Grant